Privia Health Group (PRVA) News Today → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free PRVA Stock Alerts $16.44 +0.29 (+1.80%) (As of 05/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 21 at 11:51 PM | seekingalpha.comPrivia Health: Key Lessons Learned (Rating Downgrade)May 21 at 3:40 AM | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Price Target Lowered to $19.00 at BarclaysMay 20 at 10:17 AM | marketbeat.comBarclays Lowers Privia Health Group (NASDAQ:PRVA) Price Target to $19.00Barclays cut their price objective on shares of Privia Health Group from $22.00 to $19.00 and set an "equal weight" rating for the company in a research report on Monday.May 20 at 1:43 AM | markets.businessinsider.comPrivia Health Group (PRVA) Gets a Hold from BarclaysMay 19, 2024 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Price Target Cut to $24.00 by Analysts at Truist FinancialMay 19, 2024 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Reaches New 12-Month Low at $16.81May 17, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Hits New 12-Month Low at $16.81Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year Low at $16.81May 15, 2024 | markets.businessinsider.comWhat 12 Analyst Ratings Have To Say About Privia Health GrMay 15, 2024 | marketbeat.comTruist Financial Trims Privia Health Group (NASDAQ:PRVA) Target Price to $24.00Truist Financial dropped their target price on shares of Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a report on Wednesday.May 14, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)May 14, 2024 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra Sells 13,869 SharesMay 14, 2024 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle Sells 2,232 Shares of StockMay 14, 2024 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 1,506 Shares of StockMay 14, 2024 | insidertrades.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 1,506 SharesMay 13, 2024 | marketbeat.comThomas Bartrum Sells 1,506 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) EVP Thomas Bartrum sold 1,506 shares of the business's stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $17.88, for a total transaction of $26,927.28. Following the completion of the transaction, the executive vice president now owns 102,356 shares in the company, valued at approximately $1,830,125.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.May 13, 2024 | finance.yahoo.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q1 2024 Earnings Call TranscriptMay 13, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Privia Health Group, Inc. (NASDAQ:PRVA) Lifted by AnalystMay 13, 2024 | americanbankingnews.comResearch Analysts Offer Predictions for Privia Health Group, Inc.'s Q2 2024 Earnings (NASDAQ:PRVA)May 10, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Price Target Cut to $26.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group lowered their price target on Privia Health Group from $37.00 to $26.00 and set a "buy" rating on the stock in a research report on Friday.May 10, 2024 | finance.yahoo.comPrivia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational GrowthMay 10, 2024 | finance.yahoo.comPrivia Health Group First Quarter 2024 Earnings: EPS: US$0.025 (vs US$0.064 in 1Q 2023)May 9, 2024 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Reports First Quarter 2024 Financial ResultsMay 9, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth OutlookMay 9, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Sets New 12-Month Low at $16.90Privia Health Group (NASDAQ:PRVA) Sets New 52-Week Low at $16.90May 9, 2024 | markets.businessinsider.comPrivia Health Q1 Net Profit More Than Halves; Backs FY24 Revenue OutlookMay 9, 2024 | msn.comPrivia Health Group Non-GAAP EPS of $0.18 beats by $0.03, revenue of $415.2M beats by $20.45MMay 9, 2024 | seekingalpha.comPrivia Health Group, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 9, 2024 | globenewswire.comPrivia Health Reports First Quarter 2024 Financial ResultsMay 3, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Privia Health Group (PRVA)May 3, 2024 | insidertrades.comInsider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) EVP Sells 2,252 Shares of StockMay 3, 2024 | marketbeat.comFederated Hermes Inc. Cuts Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)Federated Hermes Inc. reduced its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 91.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,403 shares of the compaMay 2, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Sells $41,481.84 in StockPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) EVP Thomas Bartrum sold 2,252 shares of the company's stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the transaction, the executive vice president now owns 103,862 shares in the company, valued at $1,913,138.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.May 1, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Price Target Lowered to $24.00 at Stifel NicolausStifel Nicolaus decreased their target price on Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a research report on Wednesday.April 23, 2024 | marketbeat.com51,400 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Acquired by Louisiana State Employees Retirement SystemLouisiana State Employees Retirement System purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,400 sApril 22, 2024 | msn.comCitigroup Initiates Coverage of Privia Health Group (PRVA) with Buy RecommendationApril 22, 2024 | markets.businessinsider.comWhere Privia Health Gr Stands With AnalystsApril 22, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at CitigroupCitigroup assumed coverage on Privia Health Group in a research report on Monday. They issued a "buy" rating and a $25.00 price target for the company.April 21, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS trimmed its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 41.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 218,025 shares of the company's stock afApril 17, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Sells 56,744 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Mirae Asset Global Investments Co. Ltd. reduced its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 25.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16April 11, 2024 | marketbeat.comPeregrine Capital Management LLC Has $5.14 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)Peregrine Capital Management LLC lessened its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 223,239 shares of the company's stock after sellApril 9, 2024 | globenewswire.comPrivia Health to Report First Quarter 2024 Results on Thursday, May 9April 5, 2024 | marketbeat.comAdvisors Preferred LLC Makes New Investment in Privia Health Group, Inc. (NASDAQ:PRVA)Advisors Preferred LLC bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 90,149 shares of the company's stock, valued at approximately $2,137,000. Advisors PApril 5, 2024 | insidertrades.comInsider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) CFO Sells 3,933 Shares of StockApril 5, 2024 | marketbeat.comRiverbridge Partners LLC Has $100.01 Million Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)Riverbridge Partners LLC increased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 8.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,342,385 shaApril 4, 2024 | marketbeat.comDavid Mountcastle Sells 3,933 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CFO David Mountcastle sold 3,933 shares of the firm's stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $17.77, for a total value of $69,889.41. Following the completion of the sale, the chief financial officer now directly owns 262,279 shares in the company, valued at $4,660,697.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.April 4, 2024 | finance.yahoo.comPRVA: Rating increased to a HOLDApril 2, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Hits New 1-Year Low at $18.07Privia Health Group (NASDAQ:PRVA) Reaches New 12-Month Low at $18.07March 30, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Position Boosted by Vanguard Group Inc.Vanguard Group Inc. increased its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 0.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,003,989 shares of the company's stock aftMarch 25, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Reaches New 52-Week Low at $19.03Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year Low at $19.03March 21, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Trading Down 4.5%Privia Health Group (NASDAQ:PRVA) Trading Down 4.5% Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Who are Nvidia’s Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” PRVA Media Mentions By Week PRVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRVA News Sentiment▼-0.290.44▲Average Medical News Sentiment PRVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRVA Articles This Week▼83▲PRVA Articles Average Week Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMEH News Today USPH News Today LFST News Today ALHC News Today PHR News Today PNTG News Today CYRX News Today WGS News Today INNV News Today KYMR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRVA) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeThis could mean the end of the U.S dollar…Colonial MetalsU.S. Drone Company Receives DoD CertificationThe Tomorrow InvestorThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeBitcoin’s Biggest Year YetParadigm PressDividend-like income from non-dividend stocksUnstoppable Prosperity[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.